AI blood test could revolutionize cancer detection
NCT ID NCT06717295
Summary
This study aims to develop and test a new blood test that uses artificial intelligence to detect cancer early and monitor how well treatment is working. Researchers will analyze RNA from blood cells in 6,000 participants, including people with 8 common cancers and healthy individuals. The goal is to create a safe, non-invasive tool to catch cancer sooner and help doctors adjust treatments based on a patient's response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Babraham Research Institute
ENROLLING_BY_INVITATIONCambridge, CB22 3AT, United Kingdom
-
Dysplasia Diagnostics Limited
RECRUITINGLondon, W1W 7LT, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NSIA- Lagos University Teaching Hospital Cancer Centre
RECRUITINGLagos, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Various Cancer Centres
ACTIVE_NOT_RECRUITINGRosario, Argentina
Conditions
Explore the condition pages connected to this study.